Translational and pharmacokinetic‐pharmacodynamic application for the clinical development of GDC‐0334, a novel TRPA1 inhibitor
Abstract GDC‐0334 is a novel small molecule inhibitor of transient receptor potential cation channel member A1 (TRPA1), a promising therapeutic target for many nervous system and respiratory diseases. The pharmacokinetic (PK) profile and pharmacodynamic (PD) effects of GDC‐0334 were evaluated in thi...
Saved in:
Main Authors: | Phyllis Chan (Author), Han Ting Ding (Author), Bianca M. Liederer (Author), Jialin Mao (Author), Paula Belloni (Author), Liuxi Chen (Author), Simon S. Gao (Author), Victory Joseph (Author), Xiaoying Yang (Author), Joseph S. Lin (Author), Mayur S. Mitra (Author), Wendy S. Putnam (Author), Angelica Quartino (Author), Rebecca N. Bauer (Author), Lin Pan (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers
by: Fei Tang, et al.
Published: (2023) -
Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC‐0214 in healthy volunteers
by: Rui Zhu, et al.
Published: (2022) -
A phase I, randomized, ascending‐dose study to assess safety, pharmacokinetics, and activity of GDC‐8264, a RIP1 inhibitor, in healthy volunteers
by: Nicholas S. Jones, et al.
Published: (2023) -
Group Dynamic Courseware (GDC): Innovative Strategic Intervention in Enhancing Basic Mathematical Skills
by: Joyce Neniel Rabor, et al.
Published: (2020) -
Search and evaluation of pharmacodynamic and pharmacokinetic parameters of selective blocker of TRPA 1 ion channels from the group of substituted pyrazinopyrimidinones
by: Evgeniya А. Beskhmelnitsyna, et al.
Published: (2018)